Canada Products

All Natural EmphyClear OTC Nasal Spray (OTC, No prescription)

  • 8 Drug Patents
  • Approved US OTC product that is produced in the US and is available in the US, Canada, Mexico
  • Drug Free, Non-Steroidal Nasal Spray for Children/Adults that is clinically proven to immediately relieve congestion

All Natural EmphyClear COPD/Asthma Spray (Prescription)

  • 8 Drug Patents
  • Drug Free, Non-Steroidal COPD/Asthma Spray for Children/Adults that has shown to help relieve clinical symptoms and improve lung function in US Phase I/II Clinical Trials
  • Completed US Phase I and Phase II Clinical Trials for COPD/Asthma/Cystic Fibrosis/Interstitial Lung/Bacterial/Viral
  • Received US FDA Orphan Drug Designation in 2005 for Cystic Fibrosis and Interstitial Lung
  • Final Phase III US Clinical Trials are planned for 2014

EmphyClear 70% Lower Steroid Nasal Spray (Prescription)

  • 8 Drug Patents
  • Completed US Clinicals for a Patented 70% lower steroid version of an well known, off-patent Nasal Spray that meets the new US FDA safety requirement and got equal or better efficacy
  • Final US Clinical Trials are planned for 2014

EmphyClear 70% Lower Steroid COPD/Asthma Spray (Prescription)

  • 8 Drug Patents
  • Completed US Clinicals for a Patented 70% lower steroid version of an well known, off-patent COPD/Asthma Spray that meets the new US FDA safety requirement and got equal or better efficacy
  • Final US Clinical Trials are planned for 2014

Alzheimer's Nasal Spray (Prescription)

  • 2 Drug Patents
  • Alzheimer's Nasal Spray for Adults that was shown to increase cognitive functions in Alzheimer’s Patients in US in a pilot I Clinical Trial
  • US Clinical Trials are planned for 2015

Smoking Cessation Oral Spray ( Prescription)

  • 2 Drug Patents
  • Smoking Cessation Oral Spray for Adults has shown to help relieve the need to smoke and Improve lung functions in US Phase I/II Clinical Trials by a Major university
  • US Clinical Trials are planned for 2015

More Medical Resources

Use of inhaled EmphyCorp drugs to kill lung cancer. Clinical trials at National Institute of health (NIH) and other Universities have confirmed that the inhalation of high doses of the EmphyCorp compound increases the production of Nitric oxide and Tumor Necrosis factor needed to kill lung cancer. Clinical trials are ongoing at a major university